Aptargroup, Inc. ATR

What this company does

Aptar designs and manufactures drug and consumer product dosing, dispensing and protection technologies. Aptar is headquartered in Crystal Lake, Illinois and has approximately 14,000 employees in approximately 20 different countries. It has approximately 5,000 customers, with no single customer or group of affiliated customers accounting for greater than 4% of its 2025 net sales. It is organized into three reporting segments: operations selling proprietary dispensing systems, drug delivery systems, sealing solutions, pharma packaging and services to the prescription drug, consumer health care, injectables, active material science solutions and digital health markets form the Pharma segment; operations selling dispensing systems and sealing solutions to the beauty, personal care and home care markets form the Beauty segment; and operations selling dispensing closures, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and other markets form the Closures segment. The Pharma segment represented approximately 46% of net sales and 43% of total assets in 2025, and accounted for 69% of Adjusted EBITDA excluding non-allocated corporate costs. The Beauty segment represented 35% of net sales and 32% of total assets in 2025, accounted for 18% of Adjusted EBITDA excluding non-allocated corporate costs, and sells pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. The Closures segment accounted for 19% of net sales and 15% of total assets in 2025, contributed 13% of Adjusted EBITDA excluding non-allocated corporate costs, and primarily sells dispensing closures. The business was started in the late 1940s, manufacturing and selling aerosol valves in the United States, and has grown through acquisitions and organic growth.

Written from the business description in APTARGROUP, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 6 February 2026. Every sentence was checked against that document before publication.